Gender-related distribution of the interleukin-1β and interleukin-1 receptor antagonist gene polymorphisms in patients with end-stage liver disease

Inflammation

Volumn 33, Issue 4, 2010, Pages 251-258

  Fontanini, Elisabetta ^a   Cussigh, Annarosa ^a   Fabris, Carlo ^a   Falleti, Edmondo ^a   Toniutto, Pierluigi ^a   Bitetto, Davide ^a   Cmet, Sara ^a   Fumolo, Elisa ^a   Fornasiere, Ezio ^a   Bignulin, Sara ^a   Pinato, David J ^b   Minisini, Rosalba ^b   Pirisi, Mario ^b  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Genetic polymorphisms; Interleukin 1 ; Liver cirrhosis; Liver transplantation

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; IL1RN PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; LINKAGE ANALYSIS; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENTIATION; VARIABLE NUMBER OF TANDEM REPEAT; AGED; ALLELE; COMPARATIVE STUDY; COMPLICATION; GENETIC PREDISPOSITION; GENETICS; HEPATITIS B; HEPATITIS C; HOMOZYGOTE; ITALY; LIVER CIRRHOSIS, ALCOHOLIC; LIVER FAILURE; LIVER TRANSPLANTATION; MIDDLE AGED; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADULT; AGED; ALLELES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HOMOZYGOTE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; ITALY; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MINISATELLITE REPEATS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; YOUNG ADULT;

EID: 77956188600     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10753-009-9179-2     Document Type: Article

References (33)

1. Iredale, J. 2008. Defining therapeutic targets for liver fibrosis: Exploiting the biology of inflammation and repair. Pharmacological Research 58: 129-136.
2. Wynn, T.A. 2008. Cellular and molecular mechanisms of fibrosis. Journal of Pathology 214: 199-210.
3. Friedman, S.L. 2008. Mechanisms of hepatic fibrogenesis. Gastroenterology 134: 1655-1669.
4. Roberts, R.A., P.E. Ganey, C. Ju, L.M. Kamendulis, I. Rusyn, and J.E. Klaunig. 2007. Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis. Toxicological Sciences 96: 2-15.
5. Wallace, K., A.D. Burt, and M.C. Wright. 2008. Liver fibrosis. Biochemical Journal 411: 1-18.
6. Tacke, F., T. Luedde, and C. Trautwein. 2009. Inflammatory pathways in liver homeostasis and liver injury. Clinical Reviews in Allergy and Immunology 36: 4-12.
7. Gieling, R.G., K. Wallace, and Y.P. Han. 2009. Interleukin-1 participates in the progression from liver injury to fibrosis. American Journal of Physiology: Gastrointestinal and Liver Physiology 296: G1324-G1331.
8. El-Omar, E.M., M. Carrington, W.H. Chow, K.E. McColl, J.H. Bream, H.A. Young, J. Herrera, J. Lissowska, C.C. Yuan, N. Rothman, G. Lanyon, M. Martin, J.F. FraumeniJr., and C.S. Rabkin. 2000. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404: 398-402.
9. Machado, J.C., P. Pharoah, S. Sousa, R. Carvalho, C. Oliveira, C. Figueiredo, A. Amorim, R. Seruca, C. Caldas, F. Carneiro, and M. Sobrinho-Simoes. 2001. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 121: 823-829.
10. Harrison, P., J.J. Pointon, K. Chapman, A. Roddam, and B.P. Wordsworth. 2008. Interleukin-1 promoter region polymorphism role in rheumatoid arthritis: A meta-analysis of IL-1B-511A/G variant reveals association with rheumatoid arthritis. Rheumatology (Oxford) 47: 1768-1770.
11. Wang, Y., N. Kato, Y. Hoshida, H. Yoshida, H. Taniguchi, T. Goto, M. Moriyama, M. Otsuka, S. Shiina, Y. Shiratori, Y. Ito, and M. Omata. 2003. Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 37: 65-71.
12. Migita, K., Y. Maeda, S. Abiru, M. Nakamura, A. Komori, S. Miyazoe, K. Nakao, H. Yatsuhashi, K. Eguchi, and H. Ishibashi.2007. Polymorphisms of interleukin-1beta in Japanese patients with hepatitis B virus infection. Journal of Hepatology 46: 381-386.
13. Hirankarn, N., I. Kimkong, P. Kummee, P. Tangkijvanich, and Y. Poovorawan. 2006. Interleukin-1beta gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection. World Journal of Gastroenterology 12: 776-779.
14. Tanaka, Y., T. Furuta, S. Suzuki, E. Orito, A.E. Yeo, N. Hirashima, F. Sugauchi, R. Ueda, and M. Mizokami. 2003. Impact of interleukin-1beta genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan. Journal of Infectious Diseases 187: 1822-1825.
15. Bahr, M.J., M. el Menuawy, K.H. Boeker, P.B. Musholt, M.P. Manns, and R. Lichtinghagen. 2003. Cytokine gene polymorphisms and the susceptibility to liver cirrhosis in patients with chronic hepatitis C. Liver International 23: 420-425.
16. Ranjbar, M., A.H. Mohammad Alizadeh, M. Hajiloi, and S.M. Mousavi. 2006. Polymorphisms of interleukin-1R receptor antagonist genes in patients with chronic hepatitis B in Iran. World Journal of Gastroenterology 12: 5044-5047.
17. Zhang, P.A., Y. Li, P. Xu, and J.M. Wu. 2004. Polymorphisms of interleukin-1B and interleukin-1 receptor antagonist genes in patients with chronic hepatitis B. World Journal of Gastroenterology 10: 1826-1829.
18. Bialek, S.R., and N.A. Terrault. 2006. The changing epidemiology and natural history of hepatitis C virus infection. Clinics in Liver Disease 10: 697-715.
19. Zhang, W.H., X.L. Wang, J. Zhou, L.Z. An, and X.D. Xie. 2005. Association of interleukin-1B (IL-1B) gene polymorphisms with risk of gastric cancer in Chinese population. Cytokine 30: 378-381.
20. Excoffier, L., G. Laval, and S. Schneider. 2005. Arlequin (version 3.0): An integrated software package for population genetics data analysis. Evol Bioinform Online 1: 47-50.
21. Barrett, J.C., B. Fry, J. Maller, and M.J. Daly. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
22. Hwang, I.R., T. Kodama, S. Kikuchi, K. Sakai, L.E. Peterson, D.Y. Graham, and Y. Yamaoka. 2002. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 123: 1793-1803.
23. Hall, S.K., D.G. Perregaux, C.A. Gabel, T. Woodworth, L.K. Durham, T.W. Huizinga, F.C. Breedveld, and A.B. Seymour. 2004. Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein. Arthritis and Rheumatism 50: 1976-1983.
24. Tountas, N.A., V. Casini-Raggi, H. Yang, F.S. Di Giovine, M. Vecchi, L. Kam, L. Melani, T.T. Pizarro, J.I. Rotter, and F. Cominelli. 1999. Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology 117: 806-813.
25. Dinarello, C.A. 1996. Biologic basis for interleukin-1 in disease. Blood 87: 2095-2147.
26. Dinarello, C.A. 2007. Mutations in cryopyrin: Bypassing roadblocks in the caspase 1 inflammasome for interleukin-1beta secretion and disease activity. Arthritis and Rheumatism 56: 2817-2822.
27. Lee, S.H., C. Stehlik, and J.C. Reed. 2001. Cop, a caspase recruitment domain-containing protein and inhibitor of caspase-1 activation processing. Journal of Biological Chemistry 276: 34495-34500.
28. Dinarello, C.A. 1998. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. International Reviews of Immunology 16: 457-499.
29. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801.
30. Dixit, V.P., R. Sinha, and R. Tank. 1986. Effect of Neem seed oil on the blood glucose concentration of normal and alloxan diabetic rats. Journal of Ethnopharmacology 17: 95-98.
31. Nakatani, T., G. Roy, N. Fujimoto, T. Asahara, and A. Ito. 2001. Sex hormone dependency of diethylnitrosamine-induced liver tumors in mice and chemoprevention by leuprorelin. Japanese Journal of Cancer Research 92: 249-256.
32. Naugler, W.E., T. Sakurai, S. Kim, S. Maeda, K. Kim, A.M. Elsharkawy, and M. Karin. 2007. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317: 121-124.
33. Rogers, A., and R. Eastell. 2001. The effect of 17beta-estradiol on production of cytokines in cultures of peripheral blood. Bone 29: 30-34.